Low-dose doxepin formulations and methods of making and using the same | Patent Number 11096920

US 11096920 B2
Application Number16779901
Publication NumberUS 20200170991 A1
Pendency1 year, 6 months, 23 days
Filled DateFeb 3, 2020
Priority DateApr 13, 2007
Publication DateJun 4, 2020
Expiration DateApr 12, 2027
Inventor/ApplicantsLuigi Schioppi
Robert Mansbach
Meredith Perry
Brian Talmadge Dorsey
Philip Jochelson
John Carter
Bryan Knox
Cara Baron Casseday
Michael Skinner
Roberta L. Rogowski
ExaminesWHEELER, THURMAN MICHAEL
Art Unit1619
Technology Center1600
Assignments
Currax Holdings Usa Llc
Current
Currax Pharmaceuticals LlcCurrax Holdings Usa Llc
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.